What can we Learn from the Disrupted in Schizophrenia 1 Interactome: Lessons for Target Identification and Disease Biology?

Growth Factors and Psychiatric Disorders

Volumn 289, Issue , 2008, Pages 208-216

  Camargo, Luiz M ^b   Wang, Qi ^a   Brandon, Nicholas J ^a  

^a PFIZER INC   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Glutamatergic neurotransmission; Measurable cognitive deficits; Physiological enzymatic role; Psychotic and cognitive symptoms; Schizophrenia and bipolar disorders

Indexed keywords

DISC1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; NDE1 PROTEIN, HUMAN; NERVE PROTEIN; NEUROLEPTIC AGENT;

BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYNAPSE;

ANTIPSYCHOTIC AGENTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, GENETIC; NERVE TISSUE PROTEINS; RISK FACTORS; SCHIZOPHRENIA; SYNAPSES;

EID: 48849099092     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470751251.ch17     Document Type: Chapter

References (27)

1. Bender AT, Beavo JA 2006 Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520.
2. Blackwood DH, Muir WJ 2004 Clinical phenotypes associated with DISC1, a candidate gene for schizophrenia. Neurotox Res 6:35-41.
3. Brandon NJ, Handford EJ, Schurov I et al 2004 Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 25:42-55.
4. Burdick KE, Hodgkinson CA, Szeszko PR et al 2005 DISC1 and neurocognitive function in schizophrenia. Neuroreport 16:1399-1402.
5. Callicott JH, Straub RE, Pezawas L et al 2005 Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 102:8627-8632.
6. Camargo LM, Collura V, Rain JC et al 2007 Disrupted in Schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry 12:74-86.
7. Cannon TD, Hennah W, van Erp TG et al 2005 Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 62:1205-1213.
8. Gandhi TK, Zhong J, Mathivanan S et al 2006 Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet 38:285-293.
9. Harrison PJ, Weinberger DR 2005 Schizophrenia genes, gene expression, and neuropathology:on the matter of their convergence. Mol Psychiatry 10:40-68.
10. Hayashi MA, Portaro FC, Bastos MF et al 2005 Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci USA 102:3828-3833.
11. Ishizuka K, Paek M, Kamiya A, Sawa A 2006 A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry 59:1189-1197.
12. Jefferson JJ, Leung CL, Liem RK 2004 Plakins: goliaths that link cell junctions and the cytoskeleton. Nat Rev Mol Cell Biol 5:542-553.
13. Kamiya A, Kubo K, Tomoda T et al 2005 A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7:1167-1178.
14. Kamiya A, Tomoda T, Chang J et al 2006 DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Hum Mol Genet 15:3313-3323.
15. Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC 2006 DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497:436-450.
16. Millar JK, Wilson-Annan JC, Anderson S et al 2000 Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415-1423.
17. Millar JK, Pickard BS, Mackie S et al 2005a DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:1187-1191.
18. Millar JK, James R, Christie S, Porteous DJ 2005b Disrupted in schizophrenia 1 (DISC1):subcellular targeting and induction of ring mitochondria. Mol Cell Neurosci 30:477-484.
19. Mohn AR, Gainetdinov RR, Caron MG, Koller BH 1999 Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
20. Ozeki Y, Tomoda T, Kleiderlein J et al 2003 Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 100:289-294.
21. Porteous DJ, Thomson P, Brandon NJ, Millar JK 2006 The genetics and biology of DISC1-an emerging role in psychosis and cognition. Biol Psychiatry 60:123-131.
22. Stefani MR, Moghaddam B 2005 Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57:433-436.
23. Talbot K, Eidem WL, Tinsley CL et al 2004 Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113:1353-1363.
24. Talbot K, Cho DS, Ong WY et al 2006 Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet 15:3041-3054.
25. Tamminga CA, Holcomb HH 2005 Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10:27-39.
26. Taya S, Shinoda T, Tsuboi D et al 2007 DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 27:15-26.
27. Zhang KY, Ibrahim PN, Gillette S, Bollag G 2005 Phosphodiesterase-4 as a potential drug target. Expert Opin Ther Targets 9:1283-1305.